ARWR vs ANF
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ARWR · Arrowhead Pharmaceuticals$41.37 ▼ 5.22%
ANF · Abercrombie & Fitch$137.92 ▲ 0.20%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ARWR -6.5%
- ANF +110.2%
Head to head
| Metric | ARWR | ANF |
|---|---|---|
| Price | $41.37 | $137.92 |
| Change today | ▼ 5.22% | ▲ 0.20% |
| Market cap | $5.85B | $5.85B |
| Return, 3 months | -52.3% | +22.7% |
| Return, year to date | -37.7% | +9.6% |
| Return, 1 year | +2.3% | +97.4% |
| P/E (TTM) | – | 11.9 |
| P/B | 116.2 | 4.3 |
| P/E percentile vs own 5y | 73rd | 52nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -85.3% | +4.8% |
| Net profit growth (YoY) | -2,760.4% | +29.4% |
| Gross margin | 99.6% | 63.7% |
| Operating margin | -156.9% | 13.7% |
| Net margin | -160.6% | 10.0% |
| Return on equity | -280.5% | 40.5% |
| Analyst target vs. price | +157.7% | +23.4% |
| Analyst buy share | 91% | 64% |
| RSI (14) | 21 | 38 |
| 30-day volatility | 64.5% | 56.1% |
| Max drawdown, 1 year | -53.8% | -45.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ANF is the largest of the group by market value.
- ANF has returned the most over the past year.
- ANF is growing revenue fastest.
- ANF keeps the most profit per dollar of sales.
- ANF has been the calmest stock over the last 30 days.